Tesabio at the OPT Congress in Boston

At Tesabio, we were glad to participate in OPT Congress 2026 in Boston, a leading event focused on oligonucleotide, mRNA, and peptide therapeutics. The meeting brought together scientists, biotech leaders, and technology providers working across discovery, development, manufacturing, and emerging therapeutic modalities.

For us, OPT was a valuable opportunity to connect with leaders in RNA therapeutics, exchange ideas on the future of the field, and introduce Tesabio’s AI-driven approach to identifying small molecules that can restore dysregulated microRNA networks in disease. The strong scientific program and highly collaborative setting made Boston an ideal place to explore new conversations around innovation and partnership.

We left the congress energized by the growing momentum in next-generation therapeutics and excited about the opportunities ahead for Tesabio.